| Michel R Nasr Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesionsMichel R Nasr Department of Pathology, State University of New York Upstate Medical University, Syracuse, NY, USA Am J Dermatopathol 30:117-22. 2008 Absence of the BRAF mutation in HBME1+ and CK19+ atypical cell clusters in Hashimoto thyroiditis: supportive evidence against preneoplastic changeMichel R Nasr Department of Pathology, State University of New York Upstate Medical University, Syracuse, USA Am J Clin Pathol 132:906-12. 2009 Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology groupMichel R Nasr Department of Pathology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA Am J Clin Pathol 127:770-8. 2007 Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME1 combined with CK19 immunostainingMichel R Nasr Department of Pathology, State University of New York Upstate Medical University, Syracuse, NY 13210, USA Mod Pathol 19:1631-7. 2006 Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell markerMichel R Nasr Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA Am J Clin Pathol 133:41-8. 2010
| |